Literature DB >> 19587665

Minicells overcome tumor drug-resistance.

Emmanouil D Karagiannis1, Daniel G Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19587665     DOI： 10.1038/nbt0709-620

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  11 in total

Review 1.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

2.  Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug.

Authors:  Jennifer A MacDiarmid; Nancy B Amaro-Mugridge; Jocelyn Madrid-Weiss; Ilya Sedliarou; Stefanie Wetzel; Kartini Kochar; Vatsala N Brahmbhatt; Leo Phillips; Scott T Pattison; Carlotta Petti; Bruce Stillman; Robert M Graham; Himanshu Brahmbhatt
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

Review 3.  Drug delivery and targeting.

Authors:  R Langer
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

Review 4.  Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors.

Authors:  Brian P Rubin; Anette Duensing
Journal:  Lab Invest       Date:  2006-08-21       Impact factor: 5.662

Review 5.  Timeline: Chemotherapy and the war on cancer.

Authors:  Bruce A Chabner; Thomas G Roberts
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

6.  Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics.

Authors:  Jennifer A MacDiarmid; Nancy B Mugridge; Jocelyn C Weiss; Leo Phillips; Adam L Burn; Richard P Paulin; Joel E Haasdyk; Kristie-Ann Dickson; Vatsala N Brahmbhatt; Scott T Pattison; Alexander C James; Ghalib Al Bakri; Rodney C Straw; Bruce Stillman; Robert M Graham; Himanshu Brahmbhatt
Journal:  Cancer Cell       Date:  2007-05       Impact factor: 31.743

7.  Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.

Authors:  Myriam Aouadi; Gregory J Tesz; Sarah M Nicoloro; Mengxi Wang; My Chouinard; Ernesto Soto; Gary R Ostroff; Michael P Czech
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

8.  Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitors.

Authors:  Jennifer A MacDiarmid; Jocelyn Madrid-Weiss; Nancy B Amaro-Mugridge; Leo Phillips; Himanshu Brahmbhatt
Journal:  Cell Cycle       Date:  2007-06-27       Impact factor: 4.534

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 10.  Knocking down barriers: advances in siRNA delivery.

Authors:  Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694
View more
  3 in total

1.  Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits.

Authors:  Michael-Joseph Gorbet; Akansha Singh; Chenkai Mao; Steven Fiering; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

Review 2.  Nanocarriers Call the Last Shot in the Treatment of Brain Cancers.

Authors:  Amin Mehrabian; Mohammad Mashreghi; Saba Dadpour; Ali Badiee; Leila Arabi; Seyedeh Hoda Alavizadeh; Seyedeh Alia Moosavian; Mahmoud Reza Jaafari
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

3.  Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

Authors:  Mohamed A Alfaleh; Christopher B Howard; Ilya Sedliarou; Martina L Jones; Reema Gudhka; Natasha Vanegas; Jocelyn Weiss; Julia H Suurbach; Christopher J de Bakker; Michael R Milne; Bree A Rumballe; Jennifer A MacDiarmid; Himanshu Brahmbhatt; Stephen M Mahler
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.